These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33805079)

  • 1. Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma.
    Lee JW; Lee JH; Park Y; Kwon J; Lee W; Song KB; Hwang DW; Kim SC
    J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33805079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
    Yamashita S; Passot G; Aloia TA; Chun YS; Javle M; Lee JE; Vauthey JN; Conrad C
    Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Carbohydrate Antigen 19-9 and the Surgical Margin in Extrahepatic Cholangiocarcinoma.
    Yamamoto R; Sugiura T; Ashida R; Ohgi K; Yamada M; Otsuka S; Uesaka K
    Ann Gastroenterol Surg; 2022 Mar; 6(2):307-315. PubMed ID: 35261957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study.
    Li XL; Liu ZP; Su XX; Gong Y; Yang YS; Zhao XL; Li ZM; Ding JJ; Zhu Y; Yin DL; Yu C; Zhou JX; Zhang D; Ding R; Chen W; Cheng Y; Yue P; Wang ZR; Zhang YQ; Jiang Y; Yin XY; Bai J; Dai HS; Lau WY; Chen ZY;
    Int J Surg; 2024 Jun; 110(6):3580-3590. PubMed ID: 38626431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.
    Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Sasaki H; Sueda T
    J Surg Oncol; 2014 Sep; 110(4):422-9. PubMed ID: 24889968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma.
    Li H; Feng Y; Liu C; Li J; Li J; Wu H; Wang G; Li D
    Front Oncol; 2021; 11():780455. PubMed ID: 35004301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
    Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
    Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
    Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
    Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
    Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
    Yamamoto Y; Sugiura T; Todaka A; Okamura Y; Ito T; Ashida R; Kakuda Y; Nakanuma Y; Uesaka K
    World J Surg; 2018 Oct; 42(10):3331-3340. PubMed ID: 29619514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma.
    Bolm L; Petrova E; Weitz J; Rückert F; Wittel UA; Makowiec F; Lapshyn H; Bronsert P; Rau BM; Khatkov IE; Bausch D; Keck T; Wellner UF; Distler M
    HPB (Oxford); 2019 Nov; 21(11):1513-1519. PubMed ID: 30956162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection.
    Chen Q; Zheng Y; Zhao H; Cai J; Wang L; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Wu J
    Ann Transl Med; 2020 Mar; 8(5):192. PubMed ID: 32309339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
    Yamada T; Nakanishi Y; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Tanaka K; Kurashima Y; Ebihara Y; Murakami S; Shichinohe T; Mitsuhashi T; Hirano S
    J Gastroenterol Hepatol; 2018 Feb; ():. PubMed ID: 29427472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection:
    Liu ZP; Cheng ZJ; Dai HS; Zhong SY; Zhao DC; Gong Y; Zuo JH; Che XY; Chen WY; Wang ZR; Yu T; Cheng JJ; Liu XC; Bai J; Jiang Y; Zhang YQ; Lau WY; Deng SQ; Chen ZY
    Front Oncol; 2022; 12():1059581. PubMed ID: 36387093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of postoperative CA19-9 normalization in patients with advanced gastric cancer.
    Kwon OK; Yu W; Chung H
    Hepatogastroenterology; 2013; 60(122):240-3. PubMed ID: 22975648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
    Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection.
    Yoo T; Park SJ; Han SS; Kim SH; Lee SD; Kim YK; Kim TH; Woo SM; Lee WJ; Hong EK
    Dis Markers; 2015; 2015():298985. PubMed ID: 26839445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup.
    Zhao J; Zhang W; Zhang J; Chen YT; Ma WJ; Liu SY; Li FY; Song B
    Cancer Manag Res; 2020; 12():13111-13123. PubMed ID: 33376403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy.
    Zhou W; Yang F; Peng J; Wang F; Lin Y; Jiang W; Yang X; Li L; Lu Z; Wan D; Pan Z; Fan W
    J Cancer; 2019; 10(16):3810-3818. PubMed ID: 31333798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.
    Lu Z; Peng J; Wang Z; Pan Z; Yuan Y; Wan D; Li B
    Med Oncol; 2016 Nov; 33(11):121. PubMed ID: 27722895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.